THU0647 INTERACTIONS BETWEEN STEPS PER DAY AND RISK

FACTORS FOR OSTEOARTHRITIS ON MRI-DETECTED OSTEOPHYTES IN A POPULATION BASED COHORT STUDY
Background: It is clear that exercise helps the symptoms of osteoarthritis. However, the relationship between physical activity (PA) and progression of knee osteoarthritis (OA) remains controversial. Moreover, no guideline on the amount of PA to prevent OA progression in general older population has been recommended, and it is still uncertain whether PA should be promoted among subgroups with knee OA such as female gender, obesity, radiographic osteoarthritis (ROA) and knee injury history. Osteophyte (OP) has long been viewed as a defining structural feature of knee OA. Recently, MRI-detected OPs have been shown to be more sensitive to change than radiographs. Objectives: The aims of this study were to describe the longitudinal association between objectively-measured PA and knee MRI-detected (OPs), and to test the interactions between PA and gender, obesity, ROA or knee injury history on the increases in MRI-detected OPs. Methods: 408 community-dwelling adults aged 51-81 were randomly selected from local community and measured at baseline and 2.6 years later. T1-weighted fat suppressed MRI was used to evaluate knee OPs at baseline and after 2.6 years. PA was assessed at baseline by pedometers (steps per day) and categorized as 3 groups: low PA (≤7499 steps per day), moderate PA (7500 to 9999 steps per day) and high PA (≥10000 steps per day). Radiographs were obtained and scored for individual features of radiographic osteoarthritis (ROA). Knee injury history was recorded by questionnaire and body mass index (BMI) was calculated. Logistic regression and log binomial regression were used in longitudinal analyses. Results: In total study sample, doing moderate PA was associated with reduced risk of an increase in MRI-detected OPs, comparing to low PA (RR=0.73, p=0.03).
There were significant interactions between PA and gender, obesity, ROA or knee injury history (all p<0.05) for an increase in MRI-detected OPs. In stratified analyses, moderate PA was protective against an increase in MRI-detected OPs in females (OR=0.23, p<0.01), obese participants (OR=0.23, p<0.01), participants with ROA (OR=0.45, p=0.02) and participants with knee injury history (OR=0.05, p=0.02). These significant associations still existed after further adjustments for age, sex, BMI, ROA and/or knee injury history (where appropriate). High PA was not associated with an increase in MRI-detected OPs in total sample or the stratified analyses but there were relatively few in this category.
Conclusions:
Moderate PA is protective for change in MRI-detected OPs in older adults, especially in those with female gender, ROA, obesity and knee injury history. This implies older people with above risks of knee OA may need to aim for a range from 7500 to 9999 steps per day. Background: According to Danish national guidelines issued in 2015, pts (pts) with inflammatory rheumatic diseases in routine care treatment with originator infliximab (INX) must switch to the cheaper biosimilar infliximab (CT-P13). This switch was done for economic reasons (CT-P13 64% cheaper than INX). Since any treatment change potentially induces additional guidance of pts and use of hospital services, it is relevant to investigate whether the switch affected use of hospital resources. Objectives: To study difference in rates of outpatient activities and services provided 6 months before vs after the switch to CT-P13 for pts treated at rheumatologic departments which provide infliximab treatment. Methods: The switch population and switch dates were identified in the Danish quality registry, DANBIO (1). Vital status was validated in the Central Person Registry. The Danish National Patient Registry (NPR) provided information regarding outpatient contacts and services. The use of 16 types of services relevant to the rheumatologic specialty was identified and included outpatient visits, infliximab infusion, nurse counselling, phone consultation, and rheumatologic ultrasound. Number of days with these services was counted. Services performed on the switch date were analyzed separately. Thus, for each patient the following rates were calculated 6 months before and after the switch: 1) days with at least one outpatient service provided, and 2) number of services provided. In addition, the weekly rate of days with services was calculated. Only pts who were alive and could be followed in the NPR for 6 full months after the switch were included. Paired t-tests were used to compare rates before and after switch. A graphical interrupted time series analysis was conducted for weekly number of services provided. Results: Among 802 pts identified, 769 had available NPR outpatient data from hospital departments of rheumatology. The 769 pts had 1484 outpatient treatment contacts at the included rheumatology departments with a total of 9243 days with services provided (including 693 on the switch date). The mean rate of days with services provided was 5.4 before the switch and 5.7 after switch (p=0.0003). The
